Amneal Pharmaceuticals, Inc. (AMRX)
USD 7.69
(-4.71%)
USD 7.69
(-4.71%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.39 Billion | 2.21 Billion | 2.09 Billion | 1.99 Billion | 1.62 Billion | 1.66 Billion |
| Cost of Revenue | 1.57 Billion | 1.42 Billion | 1.32 Billion | 1.36 Billion | 1.27 Billion | 946.58 Million |
| Gross Profit | 820.56 Million | 784.7 Million | 768.97 Million | 628.39 Million | 352.99 Million | 716.4 Million |
| Operating Expenses | 616.19 Million | 595.78 Million | 575.06 Million | 517.31 Million | 491.88 Million | 440.88 Million |
| Selling, General and Administrative Expenses | 429.67 Million | 399.7 Million | 365.5 Million | 326.72 Million | 289.59 Million | 230.43 Million |
| Research and Development Expenses | 167.77 Million | 200.04 Million | 209.56 Million | 190.58 Million | 202.28 Million | 210.45 Million |
| Other Expenses | 18.73 Million | -3.96 Million | 15.33 Million | 2.59 Million | 1.46 Million | 2.84 Million |
| Cost and Expenses | 2.18 Billion | 2.02 Billion | 1.89 Billion | 1.88 Billion | 1.76 Billion | 1.38 Billion |
| Operating Income | 204.37 Million | 206.46 Million | 209.23 Million | 91.15 Million | -137.42 Million | -19.67 Million |
| Interest Expense | 210.62 Million | 158.37 Million | 136.32 Million | 145.99 Million | 168.2 Million | 143.57 Million |
| Income Tax Expense | 8.45 Million | 6.66 Million | 11.19 Million | -104.35 Million | 383.33 Million | -1.41 Million |
| Earnings before Tax | -40.27 Million | -248.12 Million | 31.36 Million | -35.78 Million | -220.24 Million | -202.72 Million |
| Net Income | -83.99 Million | -254.78 Million | 20.17 Million | 68.57 Million | -603.57 Million | -169.72 Million |
| Earnings Per Share Basic | -0.48 | -1.69 | 0.14 | 0.47 | -4.57 | -1.33 |
| Earnings Per Share Diluted | -0.48 | -1.69 | 0.13 | 0.46 | -4.57 | -1.33 |
| Weighted Average Shares Outstanding | 176.13 Million | 150.94 Million | 148.92 Million | 147.44 Million | 132.08 Million | 127.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 176.13 Million | 150.94 Million | 151.82 Million | 148.91 Million | 132.1 Million | 127.25 Million |
| Gross Margin | 0.34 | 0.35 | 0.37 | 0.32 | 0.22 | 0.43 |
| EBIT Margin | 0.21 | 0.20 | 0.21 | 0.18 | 0.04 | 0.25 |
| Profit Margin | -0.04 | -0.12 | 0.01 | 0.03 | -0.37 | -0.10 |
| EBITDA | 500.78 Million | 150.42 Million | 450 Million | 381.04 Million | 155.19 Million | -19.67 Million |
| Earnings Before Tax Margin | 0.09 | 0.09 | 0.10 | 0.05 | -0.08 | -0.01 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 701.78 Million | 659.19 Million | 616.98 Million | 2.39 Billion | 620.04 Million | 599.04 Million |
| Cost of Revenue | 451.83 Million | 421.13 Million | 427.15 Million | 1.57 Billion | 387.5 Million | 379.02 Million |
| Gross Profit | 249.94 Million | 238.06 Million | 189.82 Million | 820.56 Million | 232.53 Million | 220.02 Million |
| Operating Expenses | 167 Million | 151.89 Million | 155.56 Million | 596.31 Million | 155.34 Million | 144.2 Million |
| Selling, General and Administrative Expenses | 116.46 Million | 112.59 Million | 109 Million | - | 113 Million | 105.57 Million |
| Research and Development Expenses | 37.09 Million | 39.29 Million | 46.56 Million | - | 42.26 Million | 38.61 Million |
| Other Expenses | 4.36 Million | 4.07 Million | 411 Thousand | 5.11 Million | 1.15 Million | 12 Thousand |
| Cost and Expenses | 618.83 Million | 573.02 Million | 582.72 Million | 2.16 Billion | 542.84 Million | 523.22 Million |
| Operating Income | 95.47 Million | -10.74 Million | 14.19 Million | 204.37 Million | 75.64 Million | 80.08 Million |
| Interest Expense | 65.71 Million | -65.7 Million | 59.54 Million | 210.62 Million | 50.9 Million | 50.85 Million |
| Income Tax Expense | 3.61 Million | 6.15 Million | 9.88 Million | 8.45 Million | -2.07 Million | -23 Thousand |
| Earnings before Tax | 20.4 Million | -75.52 Million | -83.46 Million | -40.27 Million | 22.95 Million | 29.66 Million |
| Net Income | 5.99 Million | -91.64 Million | -98.64 Million | -83.99 Million | 9.68 Million | 11.91 Million |
| Earnings Per Share Basic | 0.02 | -0.30 | -0.40 | - | 0.06 | 0.08 |
| Earnings Per Share Diluted | 0.02 | -0.30 | -0.40 | - | 0.06 | 0.08 |
| Weighted Average Shares Outstanding | 309.11 Million | 307.27 Million | 243.71 Million | 176.13 Million | 154.21 Million | 153.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 318.95 Million | 307.27 Million | 243.71 Million | 176.13 Million | 159.69 Million | 154.88 Million |
| Gross Margin | 0.36 | 0.36 | 0.31 | 0.34 | 0.38 | 0.37 |
| EBIT Margin | 0.20 | -0.02 | 0.08 | - | 0.22 | 0.22 |
| Profit Margin | 0.01 | -0.14 | -0.16 | -0.04 | 0.02 | 0.02 |
| EBITDA | 142.87 Million | -10.74 Million | 50.79 Million | - | 135.55 Million | 132.94 Million |
| Earnings Before Tax Margin | 0.14 | -0.02 | 0.02 | 0.09 | 0.12 | 0.13 |
5572
300198
DOCN
ILPMY
9878
1260